Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry M Adams

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|May 25, 2012
Therapeutic potential of a peptide targeting BCL-2 cell guardians in cancerJerry M Adams
Genes & Development|October 17, 2003
Ways of dying: multiple pathways to apoptosisJerry M Adams
Cell Research|November 16, 2019
BAX and BAK become killers without a BH3 triggerJerry M Adams
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
Donald Metcalf: The father of modern hematologyJerry M Adams, Suzanne Cory
Current Opinion in Cell Biology|December 11, 2002
Apoptosomes: engines for caspase activationJerry M Adams, Suzanne Cory
Cancer Cell|July 19, 2005
Killing cancer cells by flipping the Bcl-2/Bax switchSuzanne Cory, Jerry M Adams
Cell Death and Differentiation|November 4, 2017
The BCL-2 arbiters of apoptosis and their growing role as cancer targetsJerry M Adams, Suzanne Cory
Current Opinion in Immunology|July 17, 2007
Bcl-2-regulated apoptosis: mechanism and therapeutic potentialJerry M Adams, Suzanne Cory
Cancer Research|June 4, 2008
Is tumor growth sustained by rare cancer stem cells or dominant clones?Jerry M Adams, Andreas Strasser
Nature Reviews. Cancer|September 5, 2002
The Bcl2 family: regulators of the cellular life-or-death switchSuzanne Cory, Jerry M Adams
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|May 25, 2012
Therapeutic potential of a peptide targeting BCL-2 cell guardians in cancerJerry M Adams
Genes & Development|October 17, 2003
Ways of dying: multiple pathways to apoptosisJerry M Adams
Cell Research|November 16, 2019
BAX and BAK become killers without a BH3 triggerJerry M Adams
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
Donald Metcalf: The father of modern hematologyJerry M Adams, Suzanne Cory
Current Opinion in Cell Biology|December 11, 2002
Apoptosomes: engines for caspase activationJerry M Adams, Suzanne Cory
Cancer Cell|July 19, 2005
Killing cancer cells by flipping the Bcl-2/Bax switchSuzanne Cory, Jerry M Adams
Cell Death and Differentiation|November 4, 2017
The BCL-2 arbiters of apoptosis and their growing role as cancer targetsJerry M Adams, Suzanne Cory
Current Opinion in Immunology|July 17, 2007
Bcl-2-regulated apoptosis: mechanism and therapeutic potentialJerry M Adams, Suzanne Cory
Cancer Research|June 4, 2008
Is tumor growth sustained by rare cancer stem cells or dominant clones?Jerry M Adams, Andreas Strasser
Nature Reviews. Cancer|September 5, 2002
The Bcl2 family: regulators of the cellular life-or-death switchSuzanne Cory, Jerry M Adams
Pageof 6